FDA Approves First Generic Version of Tamiflu

Share this content:
FDA Approves First Generic Version of Tamiflu
FDA Approves First Generic Version of Tamiflu

MONDAY, Aug. 8, 2016 (HealthDay News) -- The first generic version of the flu medication Tamiflu has been approved by the U.S. Food and Drug Administration.

Tamiflu (oseltamivir phosphate) is used to treat patients 2 weeks of age and older who have had flu symptoms for no more than 48 hours. It's also used for the prevention of flu in patients 1 year of age and older. The FDA approved Tamiflu in 1999.

Oseltamivir phosphate does not take the place of seasonal flu vaccination, the FDA emphasized.

The agency also said oseltamivir phosphate does not treat or prevent illnesses caused by infections other than the flu virus, and does not prevent bacterial infections that may happen with the flu.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing

ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing

Synthetic product made from purified human hemoglobin proteins coated with a synthetic polymer

Fewer School Shootings in States With Tighter Gun Laws

Fewer School Shootings in States With Tighter Gun ...

Study also found that states that spent more money on mental health care, education saw less violence

SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years

SABCS: No Survival Benefit Seen for Letrozole Beyond ...

Study found women who continued with letrozole did experience other benefits, however

is free, fast, and customized just for you!

Already a member?

Sign In Now »